Kodiak Sciences Inc. , a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases.
Kodiak Sciences stock last closed at $14.88, up 19.23% from the previous day, and has increased 416.67% in one year. It has overperformed other stocks in the Biotechnology industry by 4.42 percentage points. Kodiak Sciences stock is currently +675% from its 52-week low of $1.92, and -23.26% from its 52-week high of $19.39.
As of Oct 15, 2025, there are 52.82M KOD shares outstanding. The market cap of KOD is $785.99M. In the past 24 hours, 1.11M KOD shares were traded.
How to Buy Kodiak Sciences Stock
Not sure how to invest in Kodiak Sciences stock? Here's how.
Choose where to buy Kodiak Sciences stock: You need to decide on a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you determine where to buy Kodiak Sciences stock.
Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Deposit funds into your brokerage account: Pick your payment method and add your info.
Analyze Kodiak Sciences stock: The Kodiak Sciences ticker symbol is KOD. Is Kodiak Sciences stock a good investment? Should you buy shares of KOD? How do KOD's underlying business fundamentals look? Do top analysts think Kodiak Sciences is a good buy? Why has KOD's stock price moved recently? (Hint: Our stock market analysis website can help you decide if KOD is a good stock to buy).
Place your KOD purchase: Decide if you will purchase KOD shares at the current market price or use a limit order to purchase KOD shares at a specific price.
Track your KOD position: Create a watchlist to monitor your new investment in Kodiak Sciences shares.
Step 1: Choose where to buy Kodiak Sciences stock
You need an online brokerage account to access the NASDAQ market and buy KOD stock.
A brokerage account is an investment account that enables you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
We believe that eToro is the best brokerage. Here's why:
Invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to world financial markets: From Technology to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've picked your brokerage, you need to fill out some personal information so you can buy KOD stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Kodiak Sciences stock
Once you have decided on the best place to buy Kodiak Sciences stock, it's critical to evaluate their stock before you invest, so you truly comprehend the risk as well as the opportunity.
Overview of key KOD info
KOD Price
$14.88
1w %
2.9%
1y %
416.67%
5y %
-80.44%
P/E
-3.92x
P/B
11.18x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$199.83M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$785.99M
Next Earnings
Nov 12, 2025
Next Dividend
N/A
Fundamentals of KOD
WallStreetZen was created to help average investors do more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on KOD's stock page.
Is KOD stock undervalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge KOD's true value.
Using relative valuations methods:
KOD may be overvalued based on its P/B ratio of 11.18x, relative to Biotechnology industry P/B ratio of 5.01x
In the last year, executives and large shareholders at KOD have sold more shares than they have bought.
John A. Borgeson, Executive Vice President and Chief Financial Officer of KOD, was the latest KOD insider to sell. They sold $2,639.67 worth of KOD stock on Jun 17, 2025.
No, Kodiak Sciences doesn't provide an income stream by paying out dividends.
What do other traders have to say about KOD?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Place your KOD purchase
There are two main order types:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are generally the easiest way to buy.
Limit order: A limit order allows you to buy or sell a stock at a specific price (or better). If you want to be certain you're buying or selling at a given dollar amount limit, use a limit order.
Click the Open button and eToro will place your order.
If you need more help investing in stocks on eToro, watch the helpful video below:
How much does it cost to buy one Kodiak Sciences share?
As of Oct 15, 2025, it costs $14.88 to buy one share of Kodiak Sciences stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $7, you can buy 0.47 shares of KOD.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.